This inventor holds 1 USPTO granted patent. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., The General Hospital Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8,586 
1 out of 486 
1 out of 3,073 
Years Active: 2021
Title: Marko Jovanovic: Innovator in CRISPR Technology
Introduction
Marko Jovanovic is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of genetic research, particularly through his innovative work involving CRISPR technology. His research focuses on the modulation of leukocyte activity, which has important implications for understanding and treating various diseases.
Latest Patents
Marko Jovanovic holds a patent titled "Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes." This invention involves a method for modulating leukocyte activity by delivering a vector containing nucleic acid molecules to leukocytes. The leukocytes are equipped with Cas9, and the vector expresses RNAs that guide Cas9 to introduce mutations in target genetic loci. This process allows for the modulation of gene expression in leukocytes, facilitating the identification of genes associated with leukocyte responses and the experimental modeling of diseases linked to aberrant leukocyte activation. The invention also enables the testing of potential treatments, including chemical compounds and gene therapies, to better understand and alleviate leukocyte-associated diseases.
Career Highlights
Throughout his career, Marko Jovanovic has worked with esteemed institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His work has been instrumental in advancing the understanding of genetic diseases and the development of therapeutic strategies.
Collaborations
Marko has collaborated with notable scientists, including Aviv Regev and Oren Parnas, contributing to a rich exchange of ideas and research advancements in the field of genetics.
Conclusion
Marko Jovanovic's innovative work in CRISPR technology and leukocyte modulation represents a significant advancement in genetic research. His contributions have the potential to lead to breakthroughs in the treatment of diseases associated with leukocytes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile